CONSOLIDATED GEMS INC COM STK (DE) (CGEM)

Are you looking for this stock instead?

Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
No data found for this quarter.
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

CONSOLIDATED GEMS INC COM STK (DE) YCharts
Yahoo! Finance finviz

Funds Holding CGEM (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CGEM BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

GADICKE ANSBERT

  • Director
  • 10% Owner
 8,195,155 2021-01-12 2

HUGHES OWEN PRESIDENT AND CEO

  • Officer
  • Director
 506,226 2021-01-12 3

TRIGILIO JEFFREY CHIEF FINANCIAL OFFICER

  • Officer
 2,250 2021-01-12 3

JOVAN-EMBIRICOS MORANA

GLOBEWAYS HOLDINGS LTD

F2 VISION SCS

F2 BIOSCIENCE I 2017 LTD

F2 MG LTD

F2 - TPO INVESTMENTS LLC

F2 BIO TD, LLC

F2 MC, LLC

F2 GC, LLC

  • Director
  • 10% Owner
 6,139,339 2021-01-12 1

UBS ONCOLOGY IMPACT FUND L.P.

ONCOLOGY IMPACT FUND (CAYMAN) MANAGEMENT L.P.

MPM ONCOLOGY IMPACT MANAGEMENT GP LLC

MPM ONCOLOGY IMPACT MANAGEMENT LP

  • 10% Owner
 7,913,887 2021-01-12 3

EBELING THOMAS

  • Director
 67,504 2021-01-07 1

BAEUERLE PATRICK SEE REMARKS

  • Officer
 341,434 2021-01-07 2

WEBSTER STEPHEN W

  • Director
 0 2021-01-07 1

KEANE RAYMOND T CHIEF LEGAL OFFICER

  • Officer
 1,624 2021-01-07 2

ROSENBERG ANTHONY

  • Director
 45,002 2021-01-07 1

JOVAN-EMBIRICOS MORANA

GLOBEWAYS HOLDINGS LTD

F2 VISION SCS

F2 BIOSCIENCE I 2017 LTD

F2 MG LTD

F2 - TPO INVESTMENTS LLC

F2 BIO TD, LLC

F2 MC, LLC

  • Director
  • 10% Owner
 112,507 2021-01-07 1

WIGGINTON JON MARC CHIEF MEDICAL OFFICER

  • Officer
 0 2021-01-07 2

UBS ONCOLOGY IMPACT FUND L.P.

  • 10% Owner
 0 2021-01-07 3

SAVILL CORRINE ACTING CHIEF BUSINESS OFFICER

  • Officer
 193,115 2021-01-07 1

ZAWEL LEIGH SEE REMARKS

  • Officer
 0 2021-01-07 2

MICHAELSON JENNIFER SEE REMARKS

  • Officer
 0 2021-01-07 2

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
CULLINAN ONCOLOGY INC CGEM 2021-08-05 22:15:04 UTC -0.4212 0.5012 15000
CULLINAN ONCOLOGY INC CGEM 2021-08-05 21:45:03 UTC -0.4212 0.5012 15000
CULLINAN ONCOLOGY INC CGEM 2021-08-05 21:15:03 UTC -0.4212 0.5012 15000
CULLINAN ONCOLOGY INC CGEM 2021-08-05 20:45:03 UTC -0.4212 0.5012 15000
CULLINAN ONCOLOGY INC CGEM 2021-08-05 20:15:04 UTC -0.4212 0.5012 15000
CULLINAN ONCOLOGY INC CGEM 2021-08-05 19:45:04 UTC -0.4212 0.5012 15000
CULLINAN ONCOLOGY INC CGEM 2021-08-05 19:15:03 UTC -0.4212 0.5012 15000
CULLINAN ONCOLOGY INC CGEM 2021-08-05 18:45:03 UTC -0.4212 0.5012 15000
CULLINAN ONCOLOGY INC CGEM 2021-08-05 18:15:03 UTC -0.4212 0.5012 15000
CULLINAN ONCOLOGY INC CGEM 2021-08-05 17:45:03 UTC -0.4212 0.5012 15000
CULLINAN ONCOLOGY INC CGEM 2021-08-05 17:15:03 UTC -0.4212 0.5012 15000
CULLINAN ONCOLOGY INC CGEM 2021-08-05 16:45:02 UTC -0.4107 0.4907 15000
CULLINAN ONCOLOGY INC CGEM 2021-08-05 16:15:03 UTC -0.4107 0.4907 15000
CULLINAN ONCOLOGY INC CGEM 2021-08-05 15:45:03 UTC -0.4107 0.4907 15000
CULLINAN ONCOLOGY INC CGEM 2021-08-05 15:15:02 UTC -0.4107 0.4907 15000
CULLINAN ONCOLOGY INC CGEM 2021-08-05 14:45:02 UTC -0.3945 0.4745 15000
CULLINAN ONCOLOGY INC CGEM 2021-08-05 14:15:04 UTC -0.3945 0.4745 15000
CULLINAN ONCOLOGY INC CGEM 2021-08-05 13:45:04 UTC -0.3945 0.4745 15000
CULLINAN ONCOLOGY INC CGEM 2021-08-05 13:15:03 UTC -0.3945 0.4745 15000
CULLINAN ONCOLOGY INC CGEM 2021-08-05 12:45:03 UTC -0.3945 0.4745 15000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments